CoChat

The DOI matches its Crossref record; 84 of the 90 references it cites were found in a registry or an index; 29 of the 47 sources its claims cite were checked for support.

SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma

Open access

Abstract

The Sonic Hedgehog (SHH) pathway is crucial regulator of embryonic development and stemness. Its alteration leads to medulloblastoma (MB), the most common malignant pediatric brain tumor. The SHH-MB subgroup is the best genetically characterized, however the molecular mechanisms responsible for its pathogenesis are not fully understood and therapeutic benefits are still limited. Here, we show that the pro-oncogenic stemness regulator Spalt-like transcriptional factor 4 (SALL4) is re-expressed in mouse SHH-MB models, and its high levels correlate with worse overall survival in SHH-MB patients. Proteomic analysis revealed that SALL4 interacts with REN/KCTD11 (here REN), a substrate receptor subunit of the Cullin3-RING ubiquitin ligase complex (CRL3 REN ) and a tumor suppressor lost in ~30% of human SHH-MBs. We demonstrate that CRL3 REN induces polyubiquitylation and degradation of wild type SALL4, but not of a SALL4 mutant lacking zinc finger cluster 1 domain (ΔZFC1). Interestingly, SALL4 binds GLI1 and cooperates with HDAC1 to potentiate GLI1 deacetylation and transcriptional activity. Notably, inhibition of SALL4 suppresses SHH-MB growth both in murine and patient-derived xenograft models. Our findings identify SALL4 as a CRL3 REN substrate and a promising therapeutic target in SHH-dependent cancers.

Overview

CoChat Summary

TL;DR

This study identifies SALL4 as a CRL3REN/KCTD11 substrate in Sonic Hedgehog (SHH)-dependent medulloblastoma and shows that SALL4 promotes tumor growth by cooperating with HDAC1 and GLI1 to enhance SHH signaling. The authors report that SALL4 inhibition suppresses SHH-MB growth in cell culture, mouse models, and patient-derived xenografts.

Key findings

  • Proteomic screening of REN/KCTD11 interactors recovered SALL4, and co-immunoprecipitation confirmed REN binds SALL4; CRL3REN promoted SALL4 polyubiquitylation and proteasomal degradation, while the SALL4 ΔZFC1 mutant was resistant to this regulation.
  • In Cavalli SHH-MB patient data (GSE85217), high SALL4 expression was associated with worse prognosis in SHH-MB patients; subtype analysis showed lower SALL4 in gamma than in alpha, beta, and delta subtypes.
  • SALL4 increased GLI1-responsive transcription in a dose-dependent manner, decreased AcGLI1 (acetyl-K518-GLI1), and formed a trimeric complex with GLI1 and HDAC1 to enhance SHH signaling.
  • SALL4 depletion reduced proliferation and SHH transcriptional output in Med1-MB cells and primary SHH-MB cells; in PDX cells, SALL4 depletion lowered the S phase from 12.75% to 4.03% and increased G2 from 6.185% to 13.75%.

Methods

  • The study combined immunoaffinity purification/mass spectrometry, co-immunoprecipitation, ubiquitination assays, luciferase reporter assays, qRT-PCR, immunoblotting, and cell proliferation/cell cycle analyses.
  • Models included HEK293T cells, Med1-MB cells, primary murine SHH-MB cells from Math1-cre/Ptcfl/fl mice, GNP cultures, and two human SHH-MB PDX models (ICN-MB-PDX12 and Med-1712FH).
  • In vivo work used heterotopic subcutaneous allografts in nu/nu mice (n = 4) and orthotopic cerebellar allografts in nu/nu mice (n = 6 per group), with tumor growth measured after SALL4 knockdown.

Limitations

  • The paper does not report detailed quantitative results for several in vivo experiments in the text provided; some outcomes are described qualitatively or refer to figures.
  • The study focuses on preclinical models and dataset analysis; no clinical intervention or prospective patient cohort is reported (stated by the text).
  • The text does not provide a full breakdown of sample sizes for all assays and datasets used, beyond the explicitly stated animal-group sizes and the two PDX models (evident from the text).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41418-023-01246-6

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 REN binds and ubiquitylates SALL4 promoting its proteasome-mediated degradation. A HEK293T cells were transfected with plasmids encoding for Flag-HA epitope tagged REN/KCTD11 or an empty vector (EV). B Cells were treated with the proteasome inhibitor MG132 and lysed. Whole cell extracts were immunoprecipitated with anti-Flag resin and eluted with Flag peptide. A second immunoprecipitation was carried out with an anti-HA antibody, which was followed by three sequential elutions with 1% SDS, as indicated. Immunocomplexes were resolved by SDS-PAGE. The gel was then stained by silver stain for protein visualization. Co-IPs of C Flag-REN and endogenous SALL4, or D Flag-REN WT or its mutants (ΔBTB, BTB) and exogenous SALL4 from HEK293Ts transiently transfected with indicated plasmids. IPs of E HA-SALL4 or F endogenous SALL4 from HEK293Ts transiently transfected with indicated plasmids. G IP of HA-SALL4 from HEK293Ts transiently transfected with indicated plasmids and treated with MG132 (50 μM, 4 h) to block proteasome, or DMSO as control. In E, F, and G anti-Flag antibody was used to detect the SALL4 polyubiquitylated forms; anti-HA or anti-SALL4 antibodies were used to re-probe blots to assess the levels of immunoprecipitated protein. Total protein lysates are shown in the Input. H, K Representative immunoblotting and I, L densitometric analysis of SALL4 protein levels in Med1-MB cells transiently transfected with indicated plasmids, and treated in K with CHX (100 μg/mL) up to 8 h to block protein synthesis. J qRT-PCR analysis of SALL4 expression in Med1-MB cells overexpressing increasing amounts of HA-REN. Representative immunoblotting of n = 3 biological replicas with similar results are shown in C–H, and K. Densitometric analysis in I and L, normalized on endogenous actin, represent the mean of n = 3 independent experiments ± SD. Data in J are normalized to endogenous Gapdh and Hprt control, expressed as the fold change (FC) versus the control sample value, and represent the mean of n = 3 independent experiments ± SD. *p < 0.05 calculated with two-sided Student’s t-test.
Fig. 1 REN binds and ubiquitylates SALL4 promoting its proteasome-mediated degradation. A HEK293T cells were transfected with plasmids encoding for Flag-HA epitope tagged REN/KCTD11 or an empty vector (EV). B Cells were treated with the proteasome inhibitor MG132 and lysed. Whole cell extracts were immunoprecipitated with anti-Flag resin and eluted with Flag peptide. A second immunoprecipitation was carried out with an anti-HA antibody, which was followed by three sequential elutions with 1% SDS, as indicated. Immunocomplexes were resolved by SDS-PAGE. The gel was then stained by silver stain for protein visualization. Co-IPs of C Flag-REN and endogenous SALL4, or D Flag-REN WT or its mutants (ΔBTB, BTB) and exogenous SALL4 from HEK293Ts transiently transfected with indicated plasmids. IPs of E HA-SALL4 or F endogenous SALL4 from HEK293Ts transiently transfected with indicated plasmids. G IP of HA-SALL4 from HEK293Ts transiently transfected with indicated plasmids and treated with MG132 (50 μM, 4 h) to block proteasome, or DMSO as control. In E, F, and G anti-Flag antibody was used to detect the SALL4 polyubiquitylated forms; anti-HA or anti-SALL4 antibodies were used to re-probe blots to assess the levels of immunoprecipitated protein. Total protein lysates are shown in the Input. H, K Representative immunoblotting and I, L densitometric analysis of SALL4 protein levels in Med1-MB cells transiently transfected with indicated plasmids, and treated in K with CHX (100 μg/mL) up to 8 h to block protein synthesis. J qRT-PCR analysis of SALL4 expression in Med1-MB cells overexpressing increasing amounts of HA-REN. Representative immunoblotting of n = 3 biological replicas with similar results are shown in C–H, and K. Densitometric analysis in I and L, normalized on endogenous actin, represent the mean of n = 3 independent experiments ± SD. Data in J are normalized to endogenous Gapdh and Hprt control, expressed as the fold change (FC) versus the control sample value, and represent the mean of n = 3 independent experiments ± SD. *p < 0.05 calculated with two-sided Student’s t-test.CC BY · PubMed Central
Fig. 2 ΔZFC1-SALL4 is a degradation-defective mutant. A Schematic representation of SALL4 WT (left panel) and SALL4 mutants (right panel): ΔZFC1-SALL4 (Δ320-486 aa); ΔZFC2-SALL4 (Δ551-662 aa); ΔZFC4-SALL4 (Δ859–1028 aa); ΔNuRD-SALL4 (Δ1-12 aa). B Co-IPs of Flag-REN and ectopic SALL4 (WT or mutants) from HEK293Ts transiently transfected with indicated plasmids and C relative binding affinities (%) normalized to immunoprecipitated Flag-REN (mean of n = 3 individual experiments ± SD). D IP of HA-SALL4 from HEK293Ts transiently transfected with indicated plasmids. WT- and ΔZFC2-SALL4 are used as controls. Anti-Flag antibody was used to detect the SALL4 polyubiquitylated forms; anti-HA antibody was used to re-probe blot to assess the levels of immunoprecipitated protein. Total protein lysates are shown in the Input. E Protein levels of WT- and ΔZFC1-SALL4 in HEK293Ts transfected with a vector encoding REN and F relative densitometric analysis. G ΔZFC1-SALL4 protein stability in HEK293Ts transfected with the indicated plasmids and treated with CHX (100 µg/mL) at different time points, with H relative densitometric analysis. Representative immunoblotting of n = 3 biological replicas with similar results are shown in B, D, E, and G. Actin-normalized densitometric analysis in F and H represent the mean of n = 3 independent experiments ± SD; *p < 0.05; **p < 0.01 calculated with two-sided Student’s t-test.
Fig. 2 ΔZFC1-SALL4 is a degradation-defective mutant. A Schematic representation of SALL4 WT (left panel) and SALL4 mutants (right panel): ΔZFC1-SALL4 (Δ320-486 aa); ΔZFC2-SALL4 (Δ551-662 aa); ΔZFC4-SALL4 (Δ859–1028 aa); ΔNuRD-SALL4 (Δ1-12 aa). B Co-IPs of Flag-REN and ectopic SALL4 (WT or mutants) from HEK293Ts transiently transfected with indicated plasmids and C relative binding affinities (%) normalized to immunoprecipitated Flag-REN (mean of n = 3 individual experiments ± SD). D IP of HA-SALL4 from HEK293Ts transiently transfected with indicated plasmids. WT- and ΔZFC2-SALL4 are used as controls. Anti-Flag antibody was used to detect the SALL4 polyubiquitylated forms; anti-HA antibody was used to re-probe blot to assess the levels of immunoprecipitated protein. Total protein lysates are shown in the Input. E Protein levels of WT- and ΔZFC1-SALL4 in HEK293Ts transfected with a vector encoding REN and F relative densitometric analysis. G ΔZFC1-SALL4 protein stability in HEK293Ts transfected with the indicated plasmids and treated with CHX (100 µg/mL) at different time points, with H relative densitometric analysis. Representative immunoblotting of n = 3 biological replicas with similar results are shown in B, D, E, and G. Actin-normalized densitometric analysis in F and H represent the mean of n = 3 independent experiments ± SD; *p < 0.05; **p < 0.01 calculated with two-sided Student’s t-test.CC BY · PubMed Central
Fig. 3 SALL4 positively regulates the SHH pathway. The transcriptional activity of A endogenous and B. C exogenous GLI1 has been assessed in the presence of ectopic SALL4 in HEK293Ts transiently transfected with a Firefly luciferase reporter gene under the control of a synthetic promoter containing 12 binding sites for GLI1 (12 × GLI1-BS), pRL-TK Renilla as normalization control, and the indicated plasmids. D GLI1-mediated transcription has been evaluated in HEK293Ts transiently transfected with constructs expressing Firefly luciferase under the control of PTCH promoter presenting a conserved (P1A WT-Luc) or mutated (P1A Mut-Luc) GLI1-BS, pRL-TK Renilla as normalization control, and the indicated plasmids. Luciferase analyses were performed 24 h after transfection. Data in A–C represent the mean of n = 3 independent experiments ± SD; data in D represent the mean of n = 4 independent experiments ± SD. All data are expressed as FC versus empty vector. Representative immunoblotting of n = 3 biological replicas with similar results showing the expression levels of transfected plasmids are reported. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 calculated with two-sided Student’s t-test.
Fig. 3 SALL4 positively regulates the SHH pathway. The transcriptional activity of A endogenous and B. C exogenous GLI1 has been assessed in the presence of ectopic SALL4 in HEK293Ts transiently transfected with a Firefly luciferase reporter gene under the control of a synthetic promoter containing 12 binding sites for GLI1 (12 × GLI1-BS), pRL-TK Renilla as normalization control, and the indicated plasmids. D GLI1-mediated transcription has been evaluated in HEK293Ts transiently transfected with constructs expressing Firefly luciferase under the control of PTCH promoter presenting a conserved (P1A WT-Luc) or mutated (P1A Mut-Luc) GLI1-BS, pRL-TK Renilla as normalization control, and the indicated plasmids. Luciferase analyses were performed 24 h after transfection. Data in A–C represent the mean of n = 3 independent experiments ± SD; data in D represent the mean of n = 4 independent experiments ± SD. All data are expressed as FC versus empty vector. Representative immunoblotting of n = 3 biological replicas with similar results showing the expression levels of transfected plasmids are reported. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 calculated with two-sided Student’s t-test.CC BY · PubMed Central
Fig. 4 SALL4 cooperates with HDAC1 in reducing GLI1 acetylation levels. A GLI1-induced transcription has been assessed in HEK293Ts transiently transfected with 12 × GLI1-BS Firefly luciferase, pRL-TK Renilla as normalization control, and the indicated plasmids; data are expressed as FC versus empty vector. Co-IPs of SALL4 and ectopic or endogenous HDAC1 (B, C, respectively), or ectopic or endogenous GLI1 (D, E, respectively) in HEK293Ts transiently transfected as indicated. F Co-IPs of GLI1, SALL4, and HDAC1 in HEK293Ts transiently transfected with vectors expressing the indicated plasmids. G Densitometric analysis of relative GLI1/SALL4 and GLI1/HDAC1 binding affinities, expressed as FC versus relative controls, are normalized to immunoprecipitated Flag-GLI1. H HEK293Ts were transfected with different combinations of indicated plasmids. Protein lysates were immunoprecipitated with anti-Flag agarose beads. One-third of immunocomplexes was probed with antibodies to the indicated proteins (1st IP), whereas two-thirds were subjected to two elutions with Flag-peptide and re-immunoprecipitated with HA-agarose beads followed by immunoblotting as indicated (2nd IP). I Co-IP of Flag-GLI1 in HEK293Ts transiently transfected with indicated plasmids. The acetylation levels of GLI1 protein at K518 residue have been assessed by using an in-house generated antibody [39]. Total protein lysates are shown in the Input. J Densitometric analysis of relative AcGLI1 levels, normalized to immunoprecipitated Flag-GLI1. K GLI1-dependent transcription has been assessed in HEK293Ts transiently transfected with 12 × GLI1-BS Firefly luciferase, pRL-TK Renilla as normalization control, and indicated plasmids. Data are expressed as FC versus empty vector. Representative immunoblotting of n = 3 biological replicas with similar results are shown in B–F, H, and I. Densitometric analysis in G and J represent the mean of n = 3 independent experiments ± SD; *p < 0.05 *p < 0.05; **p < 0.01; ***p < 0.001 calculated with two-sided Student’s t-test.
Fig. 4 SALL4 cooperates with HDAC1 in reducing GLI1 acetylation levels. A GLI1-induced transcription has been assessed in HEK293Ts transiently transfected with 12 × GLI1-BS Firefly luciferase, pRL-TK Renilla as normalization control, and the indicated plasmids; data are expressed as FC versus empty vector. Co-IPs of SALL4 and ectopic or endogenous HDAC1 (B, C, respectively), or ectopic or endogenous GLI1 (D, E, respectively) in HEK293Ts transiently transfected as indicated. F Co-IPs of GLI1, SALL4, and HDAC1 in HEK293Ts transiently transfected with vectors expressing the indicated plasmids. G Densitometric analysis of relative GLI1/SALL4 and GLI1/HDAC1 binding affinities, expressed as FC versus relative controls, are normalized to immunoprecipitated Flag-GLI1. H HEK293Ts were transfected with different combinations of indicated plasmids. Protein lysates were immunoprecipitated with anti-Flag agarose beads. One-third of immunocomplexes was probed with antibodies to the indicated proteins (1st IP), whereas two-thirds were subjected to two elutions with Flag-peptide and re-immunoprecipitated with HA-agarose beads followed by immunoblotting as indicated (2nd IP). I Co-IP of Flag-GLI1 in HEK293Ts transiently transfected with indicated plasmids. The acetylation levels of GLI1 protein at K518 residue have been assessed by using an in-house generated antibody [39]. Total protein lysates are shown in the Input. J Densitometric analysis of relative AcGLI1 levels, normalized to immunoprecipitated Flag-GLI1. K GLI1-dependent transcription has been assessed in HEK293Ts transiently transfected with 12 × GLI1-BS Firefly luciferase, pRL-TK Renilla as normalization control, and indicated plasmids. Data are expressed as FC versus empty vector. Representative immunoblotting of n = 3 biological replicas with similar results are shown in B–F, H, and I. Densitometric analysis in G and J represent the mean of n = 3 independent experiments ± SD; *p < 0.05 *p < 0.05; **p < 0.01; ***p < 0.001 calculated with two-sided Student’s t-test.CC BY · PubMed Central
Fig. 5 SALL4 knock-down inhibits the proliferation of SHH-MB cell lines. Med1-MB cells have been transiently transfected with (A–D) two small interfering RNAs (siRNAs) or (E–H) a short hairpin RNAs (shRNA) targeting SALL4 or a non-relevant control sequence (siCTR or shCTR). Cell proliferation in A and E has been measured as cell confluence calculated using the IncuCyte® Zoom software by phase-contrast images. B, F The transcript levels of SHH signature target genes are expressed as FC versus relative controls. C, G Protein levels of SALL4, GLI1, and AcGLI1 and D, H relative densitometric analysis are shown. I Med1-MB cells have been transiently transfected as indicated, and proliferation is expressed as cell confluence calculated using the IncuCyte® Zoom software by phase-contrast images. J SALL4 protein levels in Med1-MB cells transfected with siREN or siCTR. K qRT-PCR of REN silencing in this setting is shown, as well as L SALL4 densitometric analysis. M SALL4 half-life in Med1-MB cells transfected as indicated and then treated with CHX (100 µg/mL) up to 8 h; densitometric analysis is shown in N. O Med1-MB cells have been transiently transfected as indicated, and proliferation is expressed as cell confluence calculated using the IncuCyte® Zoom software by phase-contrast images. Data in A, E, I, and O are normalized to cell scans at time 0 and expressed as FC, and represent the mean of n = 3 independent experiments ± SD. Representative immunoblotting of n = 3 biological replicas with similar results are shown in C, G, J, and M. Actin-normalized densitometric analysis in D, H, L, and N represent the mean of n = 3 independent experiments ± SD. Data in B, F, and K are normalized to endogenous Gapdh and Hprt control expressed as FC respect to the control sample value and represent the mean of n = 3 independent experiments ± SD. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 calculated with two-sided Student’s t-test.
Fig. 5 SALL4 knock-down inhibits the proliferation of SHH-MB cell lines. Med1-MB cells have been transiently transfected with (A–D) two small interfering RNAs (siRNAs) or (E–H) a short hairpin RNAs (shRNA) targeting SALL4 or a non-relevant control sequence (siCTR or shCTR). Cell proliferation in A and E has been measured as cell confluence calculated using the IncuCyte® Zoom software by phase-contrast images. B, F The transcript levels of SHH signature target genes are expressed as FC versus relative controls. C, G Protein levels of SALL4, GLI1, and AcGLI1 and D, H relative densitometric analysis are shown. I Med1-MB cells have been transiently transfected as indicated, and proliferation is expressed as cell confluence calculated using the IncuCyte® Zoom software by phase-contrast images. J SALL4 protein levels in Med1-MB cells transfected with siREN or siCTR. K qRT-PCR of REN silencing in this setting is shown, as well as L SALL4 densitometric analysis. M SALL4 half-life in Med1-MB cells transfected as indicated and then treated with CHX (100 µg/mL) up to 8 h; densitometric analysis is shown in N. O Med1-MB cells have been transiently transfected as indicated, and proliferation is expressed as cell confluence calculated using the IncuCyte® Zoom software by phase-contrast images. Data in A, E, I, and O are normalized to cell scans at time 0 and expressed as FC, and represent the mean of n = 3 independent experiments ± SD. Representative immunoblotting of n = 3 biological replicas with similar results are shown in C, G, J, and M. Actin-normalized densitometric analysis in D, H, L, and N represent the mean of n = 3 independent experiments ± SD. Data in B, F, and K are normalized to endogenous Gapdh and Hprt control expressed as FC respect to the control sample value and represent the mean of n = 3 independent experiments ± SD. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 calculated with two-sided Student’s t-test.CC BY · PubMed Central
Fig. 6 SALL4 inhibition impairs SHH-dependent tumor cell growth in vitro. A-C SALL4 levels have been evaluated in protein lysates of SHH-MB tissues from Gfap-cre/Ptcfl/fl and Math1-cre/Ptcfl/fl mice and compared to the cerebella of healthy siblings (Ptcwt/wt). D Primary SHH-MB cells have been infected with lentiviral particles expressing shSALL4 or shCTR. E Cell proliferation has been measured as Nuclight relative staining calculated at indicated time points by using the IncuCyte® Zoom software. F Transcript levels of SHH target genes and G expression of SHH-related proteins are shown, with H relative densitometric analysis. I SALL4-depleted primary SHH-MB cells, and control cells, have been treated with MGCD0103 (0.5 μM, 24 h) or DMSO as control. Cell proliferation has been measured as relative Nuclight staining calculated using IncuCyte® Zoom software at the indicated time points. J SHH-MB-SLCs neurospheres were dissociated and electroporated with siRNAs to a non-relevant mRNA (siCTR) or murine SALL4 (siSALL4). Representative bright field images of tumor neurospheres were acquired with the IncuCyte® zoom software. Scale bar: 400 µm. K The proliferative capability of SHH-MB-SLCs is expressed as neurospheres-size (μm2). L Protein expression levels of SALL4, GLI1, stemness, and tumorigenic markers are shown with M relative densitometric analysis. Representative immunoblotting of n = 3 biological replicas with similar results are shown in B, G, and L. Vinculin- or actin-normalized densitometric analysis in C, H, and M represent the mean of n = 3 independent experiments ± SD. Data in E and I are normalized to cell scans at time 0 and expressed as FC and represent the mean of n = 3 independent experiments ± SD. Data in F are normalized to endogenous Gapdh and Hprt control expressed as FC respect to the control sample value and represent the mean of n = 3 independent experiments ± SD. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 versus siCTR or shCTR calculated using two-sided Student’s t-test. Schematic representations in A and D have been created by BioRender.com.
Fig. 6 SALL4 inhibition impairs SHH-dependent tumor cell growth in vitro. A-C SALL4 levels have been evaluated in protein lysates of SHH-MB tissues from Gfap-cre/Ptcfl/fl and Math1-cre/Ptcfl/fl mice and compared to the cerebella of healthy siblings (Ptcwt/wt). D Primary SHH-MB cells have been infected with lentiviral particles expressing shSALL4 or shCTR. E Cell proliferation has been measured as Nuclight relative staining calculated at indicated time points by using the IncuCyte® Zoom software. F Transcript levels of SHH target genes and G expression of SHH-related proteins are shown, with H relative densitometric analysis. I SALL4-depleted primary SHH-MB cells, and control cells, have been treated with MGCD0103 (0.5 μM, 24 h) or DMSO as control. Cell proliferation has been measured as relative Nuclight staining calculated using IncuCyte® Zoom software at the indicated time points. J SHH-MB-SLCs neurospheres were dissociated and electroporated with siRNAs to a non-relevant mRNA (siCTR) or murine SALL4 (siSALL4). Representative bright field images of tumor neurospheres were acquired with the IncuCyte® zoom software. Scale bar: 400 µm. K The proliferative capability of SHH-MB-SLCs is expressed as neurospheres-size (μm2). L Protein expression levels of SALL4, GLI1, stemness, and tumorigenic markers are shown with M relative densitometric analysis. Representative immunoblotting of n = 3 biological replicas with similar results are shown in B, G, and L. Vinculin- or actin-normalized densitometric analysis in C, H, and M represent the mean of n = 3 independent experiments ± SD. Data in E and I are normalized to cell scans at time 0 and expressed as FC and represent the mean of n = 3 independent experiments ± SD. Data in F are normalized to endogenous Gapdh and Hprt control expressed as FC respect to the control sample value and represent the mean of n = 3 independent experiments ± SD. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 versus siCTR or shCTR calculated using two-sided Student’s t-test. Schematic representations in A and D have been created by BioRender.com.CC BY · PubMed Central
Fig. 7 SALL4 inhibition impairs SHH-dependent tumor cell growth in vivo. A Representative images of SHH-MB tumors from Math1-cre/Ptcfl/fl mice immune-stained with SALL4 or Ki67 used as control of proliferating cells (magnification ×40 and ×80; scale bars: 50 µm and 25 µm, respectively). B Primary SHH-MB cells have been infected with lentiviral particles expressing shSALL4 or shCTR. After infection, 2 × 106 cells have been subcutaneously injected in both back flanks of nu/nu mice (n = 4/group). C Caliper measurements have been collected three times a week up to 35 days after injection to assess tumor growth. Quantification of D tumor explants and E representative flank allograft tumors are shown (magnification ×1; scale bar: 1 cm). F Relative transcript and G protein levels of SHH targets in explanted tumors are shown. H Protein levels are normalized to endogenous actin. I Representative hematoxylin and eosin (H&E) images and immunohistochemical staining of Ki67, GLI1, and cleaved Caspase-3 (CL. CAS-3) of representative tumor masses (magnification 20 ×; scale bar: 100 μm). J The Ki67, GLI1, and CL. CAS-3%-positive estimates have been calculated on the total of cells for each image. K Primary SHH-MB cells have been infected with lentiviral particles expressing shSALL4 or shCTR. After infection, 2 × 104 cells have been orthotopically injected in the cerebellum of nu/nu mice (n = 6/group). L Representative H&E images (low and high magnifications) of murine SHH-MB orthotopic tumors derived from primary SHH-MB cells genetically silenced for SALL4 before the injection in nu/nu mice cerebella. (magnification ×4 and ×10; scale bars: 500 µm upper panel, and 200 μm lower panel). Representative immunoblotting of at least three independent tumor grafts with similar results are shown in G. Actin-normalized densitometric analysis in H represents the mean of n = 3 independent explanted tumors ± SD. Data in F are normalized to endogenous Gapdh and Hprt control expressed as FC respect to the control sample value and represent the mean of n = 4 tumor grafts ± SD. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 versus shCTR calculated by two-sided Student’s t-test. Schematic representations in B and K have been created by BioRender.com.
Fig. 7 SALL4 inhibition impairs SHH-dependent tumor cell growth in vivo. A Representative images of SHH-MB tumors from Math1-cre/Ptcfl/fl mice immune-stained with SALL4 or Ki67 used as control of proliferating cells (magnification ×40 and ×80; scale bars: 50 µm and 25 µm, respectively). B Primary SHH-MB cells have been infected with lentiviral particles expressing shSALL4 or shCTR. After infection, 2 × 106 cells have been subcutaneously injected in both back flanks of nu/nu mice (n = 4/group). C Caliper measurements have been collected three times a week up to 35 days after injection to assess tumor growth. Quantification of D tumor explants and E representative flank allograft tumors are shown (magnification ×1; scale bar: 1 cm). F Relative transcript and G protein levels of SHH targets in explanted tumors are shown. H Protein levels are normalized to endogenous actin. I Representative hematoxylin and eosin (H&E) images and immunohistochemical staining of Ki67, GLI1, and cleaved Caspase-3 (CL. CAS-3) of representative tumor masses (magnification 20 ×; scale bar: 100 μm). J The Ki67, GLI1, and CL. CAS-3%-positive estimates have been calculated on the total of cells for each image. K Primary SHH-MB cells have been infected with lentiviral particles expressing shSALL4 or shCTR. After infection, 2 × 104 cells have been orthotopically injected in the cerebellum of nu/nu mice (n = 6/group). L Representative H&E images (low and high magnifications) of murine SHH-MB orthotopic tumors derived from primary SHH-MB cells genetically silenced for SALL4 before the injection in nu/nu mice cerebella. (magnification ×4 and ×10; scale bars: 500 µm upper panel, and 200 μm lower panel). Representative immunoblotting of at least three independent tumor grafts with similar results are shown in G. Actin-normalized densitometric analysis in H represents the mean of n = 3 independent explanted tumors ± SD. Data in F are normalized to endogenous Gapdh and Hprt control expressed as FC respect to the control sample value and represent the mean of n = 4 tumor grafts ± SD. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 versus shCTR calculated by two-sided Student’s t-test. Schematic representations in B and K have been created by BioRender.com.CC BY · PubMed Central
Fig. 8 SALL4 inhibition counteracts growth of human MBs in SHH-MB PDX cells. A Representative images of SHH-MB PDX tumor samples immuno-stained with SALL4 and Ki67 used as control of proliferating cells (magnification ×40 and ×80; scale bars: 50 µm and 25 µm, respectively). B SHH-MB PDX cells have been infected with lentiviral particles (shCTR or shSALL4). C After infection, cell proliferation has been measured as cell confluence calculated with the IncuCyte® Zoom software by phase-contrast images. Cells proliferation is normalized to scans at time 0 and is expressed as FC. D mRNA expression of SHH signature and E immunoblotting of SHH related proteins, with F relative densitometric analysis are shown. G Cell cycle analysis by FACS of SALL4-depleted SHH-MB PDX cells. Plot data of cells labeled with Click-iT EdU Pacific Blue (y-axis) and Click-iT Cell Cycle 488-Red (7-ADD) (x-axis) fluorescence. Cells were analyzed by flow cytometer with 405 nm 450/50 nm bandpass and 675/20 nm bandpass, respectively. The percentage of cells in S phase, G1 phase, and G2 phase of cell cycle, are shown. H SHH-MB PDX cells have been treated with Thal (or vehicle) at the indicated concentrations. After treatment, cells proliferation has been measured as cell confluence calculated with the IncuCyte® Zoom software by phase-contrast images. Cells growth is normalized to scans at time 0 and is expressed as FC. I Immunoblotting of SALL4 and GLI1 levels are shown. Representative immunoblotting of n = 3 independent biological replicas with similar results are shown in E and I. Actin-normalized densitometric analysis in F represents the mean of n = 3 independent explanted tumors ± SD. Data in D are normalized to endogenous Gapdh and Hprt control expressed as the FC respect to the control sample value and represent the mean of n = 3 biological replicas ± SD. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 versus shCTR calculated with two-sided Student’s t-test. J A representative model showing the new identified role of SALL4 in SHH-dependent tumorigenesis. In physiological condition, CRL3REN promotes the ubiquitylation and proteasomal degradation of both SALL4 and HDAC1. This event maintains GLI1 acetylated thus impairing its transcriptional activity. As consequence, cells proliferation is blocked. In MB, the absence of REN allows SALL4 and HDAC1 protein accumulation. SALL4, HDAC1, and GLI1 are assembled in a trimeric complex, thus promoting GLI1 deacetylation and its transcriptional activity. This event triggers the SHH pathway activation and favors cell growth and tumorigenesis. Schematic representations in B and J have been created by BioRender.com.
Fig. 8 SALL4 inhibition counteracts growth of human MBs in SHH-MB PDX cells. A Representative images of SHH-MB PDX tumor samples immuno-stained with SALL4 and Ki67 used as control of proliferating cells (magnification ×40 and ×80; scale bars: 50 µm and 25 µm, respectively). B SHH-MB PDX cells have been infected with lentiviral particles (shCTR or shSALL4). C After infection, cell proliferation has been measured as cell confluence calculated with the IncuCyte® Zoom software by phase-contrast images. Cells proliferation is normalized to scans at time 0 and is expressed as FC. D mRNA expression of SHH signature and E immunoblotting of SHH related proteins, with F relative densitometric analysis are shown. G Cell cycle analysis by FACS of SALL4-depleted SHH-MB PDX cells. Plot data of cells labeled with Click-iT EdU Pacific Blue (y-axis) and Click-iT Cell Cycle 488-Red (7-ADD) (x-axis) fluorescence. Cells were analyzed by flow cytometer with 405 nm 450/50 nm bandpass and 675/20 nm bandpass, respectively. The percentage of cells in S phase, G1 phase, and G2 phase of cell cycle, are shown. H SHH-MB PDX cells have been treated with Thal (or vehicle) at the indicated concentrations. After treatment, cells proliferation has been measured as cell confluence calculated with the IncuCyte® Zoom software by phase-contrast images. Cells growth is normalized to scans at time 0 and is expressed as FC. I Immunoblotting of SALL4 and GLI1 levels are shown. Representative immunoblotting of n = 3 independent biological replicas with similar results are shown in E and I. Actin-normalized densitometric analysis in F represents the mean of n = 3 independent explanted tumors ± SD. Data in D are normalized to endogenous Gapdh and Hprt control expressed as the FC respect to the control sample value and represent the mean of n = 3 biological replicas ± SD. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 versus shCTR calculated with two-sided Student’s t-test. J A representative model showing the new identified role of SALL4 in SHH-dependent tumorigenesis. In physiological condition, CRL3REN promotes the ubiquitylation and proteasomal degradation of both SALL4 and HDAC1. This event maintains GLI1 acetylated thus impairing its transcriptional activity. As consequence, cells proliferation is blocked. In MB, the absence of REN allows SALL4 and HDAC1 protein accumulation. SALL4, HDAC1, and GLI1 are assembled in a trimeric complex, thus promoting GLI1 deacetylation and its transcriptional activity. This event triggers the SHH pathway activation and favors cell growth and tumorigenesis. Schematic representations in B and J have been created by BioRender.com.CC BY · PubMed Central

Verification

Claims the paper makes

19 Valid · 1 Not valid · 10 Not checked · 70 Own results and interpretations

65 more claims · 2 with their cited sources checked

Create a free account to see all 100 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 16
  • It may state two separate claims as one. 16
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 90 references

Cited by

See all 13

Metadata

Authors
Lospinoso Severini, L., Loricchio, E., Navacci, S., Basili, I., Alfonsi, R., Bernardi, F., Moretti, M., Conenna, M., Cucinotta, A., Coni, S., Petroni, M., De Smaele, E., Giannini, G., Maroder, M., Canettieri, G., Mastronuzzi, A., Guardavaccaro, D., Ayrault, O., Infante, P., Bufalieri, F., & Di Marcotullio, L.
Affiliations
  • Sapienza University of Rome (IT)
  • Centre National de la Recherche Scientifique (FR)
  • Istituto Superiore di Sanità (IT)
  • Université Paris-Sud (FR)
  • Istituto Pasteur (IT)
  • Bambino Gesù Children's Hospital (IT)
  • University of Verona (IT)
Corresponding author
Bufalieri, Francesca
Venue
Cell Death & Differentiation
Published
2023-12-07
Volume
31
Issue
2
Pages
170-187
ISSN
  • 1350-9047 (ISSN-L)
  • 1476-5403
OpenAlex
W4389455285
Cited by
13
References
90
Citations by year
2026: 4 · 2025: 4 · 2024: 4 · 2023: 1
FWCI
1.15
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Differentiation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
  • PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, other-oa)
Funders
  • Dipartimenti di Eccellenza (L.232/2016, 232/2016)
  • Ministero della Salute (PRIN2017BF3PXZ)
  • Istituto Pasteur-Fondazione Cenci Bolognetti
  • Associazione Italiana per la Ricerca sul Cancro (MFAG 2021-ID. 26536, 2017BF3PXZ, IG 20801, MFAG 2021, IG 25833, IG-24329)
  • NextGenerationEU
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords
SALL4, medulloblastoma, sonic hedgehog pathway, ubiquitination, protein degradation, Gli1, HDAC1, transcriptional regulation, cancer stemness, therapeutic target, pediatric brain tumors
MeSH terms
Zinc Finger Protein GLI1, Animals, Brain Neoplasms, Cerebellar Neoplasms, DNA-Binding Proteins, Humans, Medulloblastoma, Transcription Factors, Transferases, Cell Cycle Proteins, Proteomics, Mice, Hedgehog Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma. https://app.cochat.ai/papers/10.1038/s41418-023-01246-6
The paper
Lospinoso Severini, L., Loricchio, E., Navacci, S., Basili, I., Alfonsi, R., Bernardi, F., Moretti, M., Conenna, M., Cucinotta, A., Coni, S., Petroni, M., De Smaele, E., Giannini, G., Maroder, M., Canettieri, G., Mastronuzzi, A., Guardavaccaro, D., Ayrault, O., Infante, P., . . . Di Marcotullio, L. (2024). SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma. Cell Death & Differentiation. https://doi.org/10.1038/s41418-023-01246-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.